Journal
CURRENT ISSUES IN MOLECULAR BIOLOGY
Volume 45, Issue 1, Pages 175-196Publisher
MDPI
DOI: 10.3390/cimb45010014
Keywords
apoptosis assay; bis-triazoles; cell cycle analysis; G4-DNA; Hsp90; melanoma; NCI 60 cell line panel; senescence
Categories
Ask authors/readers for more resources
In this study, the anticancer activity of the bis-triazoles MS47 and MS49 was investigated, focusing on the human melanoma MDA-MB-435 cell line. MS47 showed selective cytotoxicity against melanoma and other cancer cell lines, with sub-micromolar GI(50) and LC50 values. Both MS47 and MS49 were found to inhibit cell growth and induce apoptosis in MDA-MB-435 cells, while MS47 also arrested cells at the G0/G1 phase. Furthermore, MS49 decreased Hsp90 protein expression in melanoma cells, indicating its binding to the G4-DNA promoter of the Hsp90 gene.
Here, we describe the anticancer activity of our novel bis-triazoles MS47 and MS49, developed previously as G-quadruplex stabilizers, focusing specifically upon the human melanoma MDA-MB-435 cell line. At the National Cancer Institute (NCI), USA, bis-triazole MS47 (NCS 778438) was evaluated against a panel of sixty human cancer cell lines, and showed selective, distinct multi-log differential patterns of activity, with GI(50) and LC50 values in the sub-micromolar range against human cancer cells. MS47 showed highly selective cytotoxicity towards human melanoma, ovarian, CNS and colon cancer cell lines; in contrast, the leukemia cell lines interestingly showed resistance to MS47 cytotoxic activity. Further studies revealed the potent cell growth inhibiting properties of MS47 and MS49 against the human melanoma MDA-MB-435 cell line, as verified by MTT assays; both ligands were more potent against cancer cells than MRC-5 fetal lung fibroblasts (SI > 9). Melanoma colony formation was significantly suppressed by MS47 and MS49, and time- and dose-dependent apoptosis induction was also observed. Furthermore, MS47 significantly arrested melanoma cells at the G0/G1 cell cycle phase. While the expression levels of Hsp90 protein in melanoma cells were significantly decreased by MS49, corroborating its binding to the G4-DNA promoter of the Hsp90 gene. Both ligands failed to induce senescence in the human melanoma cells after 72 h of treatment, corroborating their weak stabilization of the telomeric G4-DNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available